XML 13 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statement of Changes In Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Receipts on Account of Shares [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 15 $ 102,351 $ 15 $ (93,399) $ 8,982
Beginning balance, shares at Dec. 31, 2020 15,444,697          
Loss for the period (1,757) (1,757)
Other comprehensive income (7) (7)
Issuance of restricted shares as compensation towards directors [1] 10 10
Issuance of restricted shares as compensation towards directors, shares [1]          
Stock-based compensation 58 58
Ending balance, value at Jun. 30, 2021 $ 15 102,409 10 8 (95,156) 7,286
Ending balance, shares at Jun. 30, 2021 15,444,697          
Beginning balance, value at Mar. 31, 2021 $ 15 102,400 37 (94,303) 8,149
Beginning balance, shares at Mar. 31, 2021 15,444,697          
Loss for the period (853) (853)
Other comprehensive income (29) (29)
Issuance of restricted shares as compensation towards directors [1] 10 10
Issuance of restricted shares as compensation towards directors, shares [1]          
Stock-based compensation 9 9
Ending balance, value at Jun. 30, 2021 $ 15 102,409 10 8 (95,156) 7,286
Ending balance, shares at Jun. 30, 2021 15,444,697          
Beginning balance, value at Dec. 31, 2021 $ 15 102,612 (6) (97,466) 5,155
Beginning balance, shares at Dec. 31, 2021 15,452,285          
Loss for the period         (2,220) (2,220)
Other comprehensive income 37 37
Issuance of restricted shares as compensation towards directors [1] 11 9 20
Issuance of restricted shares as compensation towards directors, shares [1] 7,872          
Stock-based compensation 198 198
Stock-based compensation, shares 13,105          
Ending balance, value at Jun. 30, 2022 $ 15 102,821 9 31 (99,686) 3,190
Ending balance, shares at Jun. 30, 2022 15,473,262          
Beginning balance, value at Mar. 31, 2022 $ 15 102,763 11 1 (98,559) 4,231
Beginning balance, shares at Mar. 31, 2022 15,452,285          
Loss for the period (1,127) (1,127)
Other comprehensive income 30 30
Issuance of restricted shares as compensation towards directors [1] 11 (2) 9
Issuance of restricted shares as compensation towards directors, shares [1] 7,872          
Stock-based compensation 47 47
Stock-based compensation, shares 13,105          
Ending balance, value at Jun. 30, 2022 $ 15 $ 102,821 $ 9 $ 31 $ (99,686) $ 3,190
Ending balance, shares at Jun. 30, 2022 15,473,262          
[1] Actual issuance occurred subsequent to the balance sheet date.